News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Kintz Samuel
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/26/2023 |
4
| Kintz Samuel (President and CEO) has filed a Form 4 on Enliven Therapeutics, Inc.|
Txns:
| Sold 12,000 shares
@ $13.8076, valued at
$165.7k
Exercised 12,000 options to buy
@ $1.12, valued at
$13.4k
|
|
| 02/27/2023 |
4
| Kintz Samuel (President and CEO) has filed a Form 4 on Enliven Therapeutics, Inc.|
Txns:
| Granted 1,087,525 shares
@ $0
Granted 88,531 shares
@ $0
Granted 88,531 shares
@ $0
Granted 344,550 options to buy
@ $1.12, valued at
$385.9k
Granted 404,363 options to buy
@ $2.48, valued at
$1M
|
|
| 02/27/2023 |
3
| Kintz Samuel (President and CEO) has filed a Form 3 on Enliven Therapeutics, Inc. |
| 02/27/2023 |
3
| Kintz Samuel (President and CEO) has filed a Form 3 on Enliven Therapeutics, Inc. |
|
|